Quanterix Corporation
NASDAQ:QTRXMedical - Devices
+$0.46 today
- Market cap
- $98.28M
- Beta
- 1.12
- P/E (TTM)
- -1.5
- EPS (TTM)
- -$2.22
Volume 3.54M
Average 1.15M
QTRX Weighted Avg Shares
Average number of basic shares outstanding during the period, used to calculate basic EPS.
Quanterix CorporationNASDAQ: QTRX
Weighted Avg Shares · Q1 FY2026 · quarter ended Mar 2026
Weighted avg shares growth accelerates
Q1 FY2026 weighted avg shares of 46.98M shares rose 21.3% year over year, ahead of the +16.0% change in trailing-twelve-month weighted avg shares. Sequentially, it rose 0.4% from the prior quarter. Over 3 fiscal years it compounded at +4.9% a year.
Context
- Weighted avg shares increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +21.3% holds above the trailing-twelve-month pace of +16.0%.
Sources:Income StatementText generated from reported figures; not investment advice.
Weighted Avg Shares history
Shares · from the income statement
- Latest · FY2025
- 42.64M USD
- Year-over-year change
- +11.1%
- 4-year CAGR
- +4.3%
| Period | Period end | Weighted Avg Shares | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 42.64M | +11.1% |
| FY2024 | 2024-12-31 | 38.37M | +2.1% |
| FY2023 | 2023-12-31 | 37.59M | +1.6% |
| FY2022 | 2022-12-31 | 36.99M | +2.8% |
| FY2021 | 2021-12-31 | 36M | — |
Weighted Avg Shares vs competitors
How QTRX compares with its peers on the latest reported figures
- QTRX's LTM Mar 2026 weighted avg shares of 44.68M shares is the 3rd highest of the 11 companies compared; the peer median is 37.45M shares.
- Its year-over-year change of +16.0% is the 5th highest of 11, against a peer median of +12.5%.
- Over three fiscal years its annual growth of +4.9% compares with a peer median of +7.9%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Dec 2025 | 64.81M | +10.5% | +7.4% | |
| LTM Mar 2026 | 52.81M | +4.4% | +2.9% | |
| LTM Mar 2026 | 44.68M | +16.0% | +4.9% | |
| LTM Mar 2026 | 40.92M | +29.8% | +18.6% | |
| LTM Mar 2026 | 40.57M | +23.7% | +21.3% | |
| LTM Mar 2026 | 38.65M | -1.0% | +0.2% | |
| LTM Mar 2026 | 36.25M | +4.5% | +4.8% | |
| LTM Mar 2026 | 26.97M | +12.1% | +5.9% | |
| LTM Mar 2026 | 26.2M | +12.8% | +8.3% | |
| LTM Mar 2026 | 17.93M | +423.3% | +68.0% | |
| LTM Mar 2026 | 8.57M | +83.3% | +80.1% | |
| Peer median (excluding QTRX) | 37.45M | +12.5% | +7.9% | |
Competitors are the stored peer set for QTRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 110.56M | 105.52M | 121.14M | 135.44M | 138.65M |
| Cost of Revenue | 45.78M | 60.16M | 48.14M | 54.32M | 73.94M |
| Gross Profit | 64.77M | 45.36M | 73M | 81.12M | 64.72M |
| Gross Margin | 58.6% | 43.0% | 60.3% | 59.9% | 46.7% |
| Research & Development | 28.38M | 26.81M | 26.06M | 31.08M | 35.92M |
| Selling, General & Admin | 92.91M | 91.85M | 92.82M | 104.64M | 138.85M |
| Operating Expenses | 121.29M | 149.63M | 118.99M | 133.74M | 174.53M |
| Depreciation & Amortization | 4.88M | 5.41M | 8.29M | 8.36M | 18.93M |
| EBITDA | (50.3M) | (67.89M) | (36.37M) | (29.74M) | (93.35M) |
| EBITDA Margin | -45.5% | -64.3% | -30.0% | -22.0% | -67.3% |
| Operating Income | (56.52M) | (104.26M) | (45.99M) | (52.62M) | (109.82M) |
| Operating Margin | -51.1% | -98.8% | -38.0% | -38.8% | -79.2% |
| Interest Income | 0 | 5.13M | 15.84M | 14.66M | 8.57M |
| Interest Expense | 403K | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 937K | 4.85M | 18.36M | 14.52M | (2.46M) |
| Income Before Tax | (55.58M) | (99.41M) | (27.64M) | (38.1M) | (112.27M) |
| Pre-Tax Margin | -50.3% | -94.2% | -22.8% | -28.1% | -81.0% |
| Income Tax Expense | (36K) | 164K | 719K | 434K | (5.12M) |
| Net Income | (55.55M) | (99.57M) | (28.35M) | (38.53M) | (107.15M) |
| Net Margin | -50.2% | -94.4% | -23.4% | -28.4% | -77.3% |
| EPS (Basic) | (1.60) | (2.61) | (0.86) | (1.00) | (2.51) |
| EPS (Diluted) | (1.60) | (2.61) | (0.86) | (1.00) | (2.51) |
| Weighted Avg Shares | 36M | 36.99M | 37.59M | 38.37M | 42.64M |
| Weighted Avg Shares (Diluted) | 36M | 36.99M | 37.59M | 38.37M | 42.64M |
Quanterix Corporation
NASDAQ:QTRX
Intrinsic Alpha fair value
Locked
Current Price
$2.07
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.